Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Why Heron Therapeutics Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket

Published 24/03/2023, 12:21
Updated 24/03/2023, 13:40
© Reuters.  Why Heron Therapeutics Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket

Benzinga - Gainers

  • Bird Global, Inc. (NYSE: BRDS) shares rose 58.7% to $0.2250 in pre-market trading after gaining more than 17% on Thursday. Bird announced plans to expand across Greater Toronto area this spring.
  • Dermata Therapeutics, Inc. (NASDAQ: DRMA) gained 24.3% to $2.09 in pre-market trading after jumping 25% on Thursday. Maxim Group maintained Dermata Therapeutics with a Buy and lowered the price target from $16 to $4.
  • Siyata Mobile Inc. (NASDAQ: SYTA) gained 23.8% to $0.2097 in pre-market trading.
  • Clean Energy Technologies, Inc. (NASDAQ: CETY) climbed 22.8% to $4.88 in pre-market trading. Clean Energy Technologies reported the pricing of its underwritten public offering of 975,000 shares of common stock at $4.00 per share.
  • Troika Media Group, Inc. (NASDAQ: TRKA) rose 19.6% to $0.2136 in pre-market.
  • Aptinyx Inc. (NASDAQ: APTX) shares rose 18.3% to $0.2110 in pre-market trading. Aptinyx was granted European patent titled 'Spiro-lactam Nmda Receptor Modulators And Uses Thereof (for The Treatment Of Conditions Such As Depression And Related Disorders).'
  • Disc Medicine Opco Inc (NASDAQ: IRON) gained 16.5% to $26.61 in pre-market trading after gaining over 5% on Thursday. BMO Capital initiated coverage on Disc Medicine with an Outperform rating and announced a price target of $40.
  • Virgin Orbit Holdings, Inc. (NASDAQ: VORB) shares rose 14.4% to $0.6101 in pre-market trading. Virgin Orbit said on Thursday that it is in talks with "interested parties" about an investment in the company.
  • Heron Therapeutics, Inc. (NASDAQ: HRTX) rose 11.8% to $2.31 in pre-market trading after posting upbeat Q4 results.
  • Helbiz, Inc. (NASDAQ: HLBZ) shares rose 9.6% to $0.1241 in pre-market trading after declining around 4% on Thursday.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .
Losers
  • Boxed, Inc. (NYSE: BOXD) fell 24.4% to $0.26 in pre-market trading after gaining 91% on Thursday. Boxed recently said it is evaluating potentially filing for relief under the U.S. Bankruptcy Code and other strategic alternatives.
  • DiamondHead Holdings Corp. (NASDAQ: DHHC) fell 12.8% to $16.50 in pre-market trading after gaining more than 82% on Thursday. DiamondHead entered into convertible note purchase agreement dated March 21, 2023.
  • Ampio Pharmaceuticals, Inc. (NYSE: AMPE) fell 11.3% to $0.2050 in pre-market after dropping more than 10% on Thursday.
  • FiscalNote Holdings, Inc. (NYSE: NOTE) fell 10.1% to $2.14 in pre-market trading. FiscalNote shares jumped 75% on Thursday after the company announced it was selected by OpenAI for collaboration as an inaugural launch partner for OpenAI's ChatGPT plug-in.
  • TC Biopharm (Holdings) Plc (NASDAQ: TCBP) shares dropped 9.1% to $2.10 in pre-market trading after dropping over 20% on Thursday. TC Biopharm recently announced corporate restructuring.
  • HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM) shares fell 6.9% to $3.12 in pre-market trading after gaining over 22% on Thursday.
  • Flora Growth Corp. (NASDAQ: FLGC) fell 6.4% to $0.2620 in pre-market trading. Flora Growth is expected to host its 2022 year-end earnings call on Monday, April 3, 2023.
  • SMX (Security Matters) Public Limited Company (NASDAQ: SMX) shares fell 6.2% to $1.21 in pre-market trading after jumping over 35% on Thursday.
  • Ouster, Inc. (NYSE: OUST) fell 6% to $0.8499 in pre-market trading after the company reported downbeat Q4 results and issued weak Q1 sales forecast.
  • Silvergate Capital Corporation (NYSE: SI) fell 5.3% to $1.07 in pre-market trading after dropping over 14% on Thursday.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.